Remon Helmy | Associate Director HEOR
Alexion
With over 10 years of experience in the fields of health economics and outcomes research (HEOR) and Real-World Evidence (RWE) and 5 years in the clinical field, I am passionate about generating and communicating evidence to support the value proposition of innovative therapies for rare diseases. As an Associate Director of HEOR at Alexion Pharmaceuticals, I lead the design and execution of global and regional projects, collaborating with cross-functional teams and external partners to deliver high-quality and timely deliverables. I am motivated by the mission of Alexion to transform the lives of people with rare and devastating diseases, and I strive to bring diverse perspectives and experiences to the team, having worked and studied in different countries and cultures. My educational background includes BSc. in Pharmacy, MSc in Health Economics, PhD in Treatment Adherence and an MBA.
Appearances:
Day 2 - Wednesday 29 October @ 11:45
Panel: From Clinical Evidence to Equitable Access: Navigating Joint Clinical Assessment in Rare Diseases
This session will explore the evolving landscape of Joint Clinical Assessments (JCAs) and their potential impact on equitable access to orphan drugs in Europe. Participants will delve into key lessons learned from ongoing JCAs, examining how evidence frameworks, PICO development, and expert involvement could be shaping clinical evaluations in the future. The discussion will highlight both the new opportunities and risks that JCAs present for orphan medicines. Thought a multi-stakeholder discussion, strategies for overcoming potential challenges will be proposed, including the early identification and simulation of PICOs and approaches for aligning evidence generation with JCA and national HTA requirements. Attendees will gain actionable insights into maximizing access and positive outcomes for patients with rare diseases in the context of rapidly evolving clinical assessment landscape
Created by
Terrapinn is proud to be a member of isla.
Working together to build sustainable events